Demant A/S (WILLF)
OTCMKTS · Delayed Price · Currency is USD
36.53
0.00 (0.00%)
Feb 11, 2026, 4:00 PM EST
Demant Market Cap
Demant has a market cap or net worth of $6.02 billion as of February 12, 2026. Its market cap has decreased by -31.36% in one year.
Market Cap
6.02B
Enterprise Value
9.16B
Revenue
3.61B
Ranking
n/a
PE Ratio
24.79
Stock Price
$36.53
Market Cap Chart
Since November 21, 1995, Demant's market cap has increased from 388.01M to 6.02B, an increase of 1,451.81%. That is a compound annual growth rate of 9.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 6.02B | -16.61% |
| Dec 30, 2025 | 7.22B | -9.80% |
| Dec 30, 2024 | 8.00B | -15.86% |
| Dec 29, 2023 | 9.51B | 56.03% |
| Dec 30, 2022 | 6.10B | -50.08% |
| Dec 30, 2021 | 12.21B | 28.27% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OpGen | 337.95M |
| Tian'an Technology Group | 145.66M |
| Zomedica | 124.94M |
| Positron | 80.21M |
| RetinalGenix Technologies | 59.54M |
| CS Diagnostics | 59.50M |
| Vivos | 31.43M |
| Guided Therapeutics | 28.51M |